Sticking to the belief of "Creating products of high quality and making friends with people from all over the world", we always put the interest of customers in the first place for Single Cell Sequence Amplification Supplier, Capture Series Suppliers, Bio-Medicine Factories, Automated Pipetting System Manufacturers, Target Validation Factories.We sincerely welcome you come to visit us. Hope we have good cooperation in the future. The product will supply to all over the world, such as Europe, America, Australia, Cambodia ,Brazil ,South Africa ,Please feel cost-free to send us your specifications and we'll respond to you asap. We've got a professional engineering team to serve for the every single detailed needs. Free samples may be sent for you personally to know far more facts. So that you can meet your desires, please really feel cost-free to contact us. You could send us emails and call us straight. Additionally, we welcome visits to our factory from all over the world for much better recognizing of our corporation. nd merchandise. In our trade with merchants of several countries, we often adhere to the principle of equality and mutual advantage. It is our hope to market, by joint efforts, both trade and friendship to our mutual benefit. We look forward to getting your inquiries.
This kit is designed for the detection of host cell protein residues in process samples of biologics (such as antibodies, recombinant proteins, vaccines, etc.) expressed in CHO cell lines.
T7 RNA Polymerase (T7 RNA polymerase) is a DNA-dependent 5'→3' RNA polymerase that recognizes the T7 promoter sequence with high specificity ,can be used for transcriptional synthesis of mRNA in IVT.
The dsRNA sequence synthesized by UTP modified in vitro transcription is intended to be used as a standard for dsRNA residue detection.
The dsRNA sequence synthesized by Pseudouridine-UTP modified in vitro transcription is intended to be used as a standard for dsRNA residue detection.
The dsRNA sequence synthesized by N1-me-pseudo-UTP modified in vitro transcription is intended to be used as a standard for dsRNA residue detection.
A next-generation T7 RNA polymerase engineered to minimize dsRNA byproducts by up to 100×, enabling safer and more efficient mRNA therapeutics.
